Hertility Health Secures £4.2 Million for Women's Health
Hertility Health, a pioneering startup in the realm of women's health based in the UK, has recently secured an impressive £4.2 million in seed funding. This funding round was notably led by prominent investors such as LocalGlobe and Venrex, alongside a select group of influential angel investors, including Evelyn Bourke, the former CEO of Bupa, and Matt Robinson, the current CEO of Nested and a key player from the highly successful unicorn company GoCardless. The financial backing will be instrumental in assisting Hertility Health’s ambitious growth plans and its mission to enhance women's health services across various facets of reproductive care.
With the funds raised, Hertility Health intends to broaden its offerings significantly.
This expansion will encompass vital services including fertility and hormone testing, menopause support, miscarriage care, as well as testing for polycystic ovarian syndrome (PCOS) and endometriosis. Furthermore, the company aims to bolster its clinical trials, which are designed to shorten the duration required to diagnose some of the most prevalent reproductive disorders. In addition to these initiatives, Hertility Health is committed to establishing itself as a scientific and clinical educational health hub specifically dedicated to the needs of women, ultimately striving to become a trusted resource within the healthcare landscape.
At the helm of this innovative company are three talented founders: Dr. Natalie Getreu, who serves as the COO, Dr. Helen O’Neill, the CEO, and Deirdre O’Neill, the CCO. They have built a science-driven network that emphasizes the importance of reproductive and hormone health, aiming to provide a comprehensive care experience. Hertility Health's approach includes not only testing but also a well-structured triage system that connects women with licensed experts and clinics, ensuring that they receive a personalized care pathway. So far, the company has successfully helped over 2,000 women gain a clearer understanding of their reproductive health and infertility risks. Through collaboration with leading experts, Hertility Health offers tailored solutions related to symptom management, egg freezing, and IVF, underscoring its commitment to empowering women’s health.
They've invested in Hertility Health
Get to know these Healthtech investors
Click here for a full list of 7,589+ startup investors in the UK